- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.8%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option and its peers as on 27 March, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| ITI Pharma and Healthcare Fund - Regular Plan - Growth Option | -4.38% | -0.8% | 0.06% | -3.28% | -4.97% | -4.09% | 19.17% | - | - | - |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 0.55% | 1.53% | 0.72% | -1.75% | 0.14% | 1.62% | 25.71% | 17.69% | 20.08% | 11.98% |
| SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth | -12.73% | -2.24% | -0.96% | -10.63% | -12.2% | -4.03% | 11.57% | 10.03% | 11.14% | 11.59% |
| SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH | -10.65% | -2.07% | -2.18% | -9.57% | -9.95% | -3.66% | 17.67% | 18.43% | 16.97% | 15.43% |
| SBI PSU Fund - REGULAR PLAN -Growth | -2.43% | -1.52% | -2.45% | -10.58% | -0.43% | 10.78% | 31.38% | 26.04% | 18.13% | 14.89% |
| SBI CONSUMPTION OPPORTUNITIES FUND - REGULAR - GROWTH | -13.17% | -2.07% | -1.11% | -8.78% | -13.32% | -9.91% | 10.43% | 14.14% | 12.43% | 13.66% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | - | -8.89% | 32.42% | 41.76% | -10.78% |
Discrete returns (monthly)
| Month | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 0.02% | 3.21% | 2.32% | -1.92% | -1.63% | 2.13% | -1.19% | -2.59% | -6.96% | 6.8% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|
| Returns | -7.83% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 98.31% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 1.69% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 10.96% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 8.97% |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 6.35% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 5.71% |
| Torrent Pharmaceuticals Limited | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 4.51% |
| Cohance Lifesciences Limited | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 4.43% |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 3.98% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 3.70% |
| Aster DM Healthcare Limited | ASTERDM (INE914M01019) | Healthcare Services | 3.62% |
| Cipla Limited | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 3.07% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 3.04% |
| Alkem Laboratories Limited | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.95% |
| Neuland Laboratories Limited | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 2.82% |
| Dr. Reddy's Laboratories Limited | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 2.57% |
| Wockhardt Limited | WOCKPHARMA (INE049B01025) | Pharmaceuticals & Biotechnology | 2.27% |
| Abbott India Limited | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 2.20% |
| Healthcare Global Enterprises Limited | HCG (INE075I01017) | Healthcare Services | 1.77% |
| Glenmark Pharmaceuticals Limited | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 1.73% |
| Laurus Labs Limited | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 1.69% |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 1.53% |
| FDC Limited | FDC (INE258B01022) | Pharmaceuticals & Biotechnology | 1.40% |
| Sumitomo Chemical India Limited | SUMICHEM (INE258G01013) | Fertilizers & Agrochemicals | 1.35% |
| SBI Life Insurance Company Limited | SBILIFE (INE123W01016) | Insurance | 1.25% |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 1.23% |
| Mankind Pharma Limited | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 1.22% |
| Biocon Limited | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.21% |
| Onesource Specialty Pharma Limited | ONESOURCE (INE013P01021) | Pharmaceuticals & Biotechnology | 1.19% |
| Rainbow Childrens Medicare Limited | RAINBOW (INE961O01016) | Healthcare Services | 1.19% |
| Orchid Pharma Limited | ORCHPHARMA (INE191A01027) | Pharmaceuticals & Biotechnology | 1.13% |
| Piramal Pharma Limited | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 1.13% |
| Standard Glass Lining Technology Ltd | SGLTL (INE0M4D01010) | Industrial Manufacturing | 1.05% |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 0.99% |
| Poly Medicure Limited | POLYMED (INE205C01021) | Healthcare Equipment & Supplies | 0.93% |
| Caplin Point Laboratories Limited | CAPLIPOINT (INE475E01026) | Pharmaceuticals & Biotechnology | 0.86% |
| Supriya Lifescience Limited | SUPRIYA (INE07RO01027) | Pharmaceuticals & Biotechnology | 0.85% |
| Linde India Limited | LINDEINDIA (INE473A01011) | Chemicals & Petrochemicals | 0.81% |
| Shilpa Medicare Limited | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 0.75% |
| UPL Limited | UPL (INE628A01036) | Fertilizers & Agrochemicals | 0.72% |
| Zydus Lifesciences Limited | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 0.70% |
| Syngene International Limited | SYNGENE (INE398R01022) | Healthcare Services | 0.48% |
Debt
| Name | Rating | Weight % |
|---|
Portfolio data is as on date 31 October, 2025
NAV history
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 27 March, 2026 | 14.9568 | -0.8% |
| 25 March, 2026 | 15.0767 | 1.6% |
| 24 March, 2026 | 14.8388 | 1.6% |
| 23 March, 2026 | 14.6054 | -2.29% |
| 20 March, 2026 | 14.9482 | 1.44% |
| 19 March, 2026 | 14.7361 | -2.4% |
| 18 March, 2026 | 15.0992 | 0.47% |
| 17 March, 2026 | 15.0283 | 0.78% |
| 16 March, 2026 | 14.9115 | -1.09% |
| 13 March, 2026 | 15.0764 | -2.01% |
| 12 March, 2026 | 15.3857 | -0.65% |
| 11 March, 2026 | 15.4865 | 0.19% |
| 10 March, 2026 | 15.4571 | -0.66% |
| 9 March, 2026 | 15.5596 | -0.2% |
| 6 March, 2026 | 15.5901 | 0.25% |
| 5 March, 2026 | 15.5507 | 0.68% |
| 4 March, 2026 | 15.4456 | -1.47% |
| 2 March, 2026 | 15.6759 | 1.37% |
| 27 February, 2026 | 15.4636 | -1.03% |
| 26 February, 2026 | 15.6247 | 0.99% |
| 25 February, 2026 | 15.4714 | 1.05% |
| 24 February, 2026 | 15.3105 | -0.22% |
| 23 February, 2026 | 15.3440 | 0.94% |
| 20 February, 2026 | 15.2015 | -0.16% |
| 19 February, 2026 | 15.2251 | -0.57% |
| 18 February, 2026 | 15.3123 | 0.44% |
| 17 February, 2026 | 15.2456 | 0.53% |
| 16 February, 2026 | 15.1655 | 0.75% |
| 13 February, 2026 | 15.0528 | -0.99% |
| 12 February, 2026 | 15.2036 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The latest NAV of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option is 14.9568 as on 27 March, 2026.What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are -4.38% as on 27 March, 2026.What are 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are -4.09% as on 27 March, 2026.What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 19.17% as on 27 March, 2026.